TECXTectonic Therapeutic, Inc.

$635M

Q4 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$436,000

Operating Income

-$28M

Net Income

-$28M

EPS (Diluted)

$-7.76

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$26M

Free Cash Flow

-$27M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$33M

Total Liabilities

$48M

Stockholders' Equity

-$15M

Cash & Equivalents

$28M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$436,000	-$309,000	-41.1%
Operating Income	-$28M	-$28M	+0.4%
Net Income	-$28M	-$28M	-0.3%

TECX Q4 2021 Earnings — Tectonic Therapeutic, Inc. Revenue & Financial Results | Market Cap Arena